Defective hematopoietic stem cell and lymphoid progenitor development in the ts65dn mouse model of down syndrome: Potential role of oxidative stress

Antioxidants and Redox Signaling

Volumn 15, Issue 8, 2011, Pages 2083-2094

  Lorenzo, Laureanne Pilar E ^a   Chen, Haiyan ^a   Shatynski, Kristen E ^a   Clark, Sarah ^a   Yuan, Rong ^b   Harrison, David E ^b   Yarowsky, Paul J ^a   Williams, Mark S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7 RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HEMATOPOIETIC STEM CELL; IMMUNOPATHOLOGY; IN VITRO STUDY; LYMPHOID PROGENITOR CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; DOWN SYNDROME; FEMALE; HEMATOPOIETIC STEM CELLS; LYMPHOID PROGENITOR CELLS; MALE; MICE; MICE, MUTANT STRAINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, INTERLEUKIN-7;

MUS;

EID: 80052606865     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3798     Document Type: Article

References (46)

1. Akashi K, Traver D, Miyamoto T, and Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197, 2000. (Pubitemid 30154488)
2. Allman D, Sambandam A, Kim S, Miller JP, Pagan A, Well D, Meraz A, and Bhandoola A. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 4: 168-174, 2003. (Pubitemid 36193019)
3. Bensaad K and Vousden KH. Savior and slayer: the two faces of p53. Nat Med 11: 1278-1279, 2005. (Pubitemid 41752901)
4. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, SykesM, and Scadden DT. Hematopoietic stemcell quiescence maintained by p21cip1/waf1. Science 287: 1804-1808, 2000.
5. Cheshier SH, Morrison SJ, Liao X, and Weissman IL. In vivo proliferation and cell cycle kinetics of long-term selfrenewing hematopoietic stem cells. Proc Natl Acad Sci USA 96: 3120-3125, 1999. (Pubitemid 29148854)
6. Cochrane SW, Zhao Y, Welner RS, and Sun XH. Balance between Id and E proteins regulates myeloid-versuslymphoid lineage decisions. Blood 113: 1016-1026, 2009.
7. Day SM, Strauss DJ, Shavelle RM, and Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol 47: 171-176, 2005. (Pubitemid 40277822)
8. DeKoter RP, Schweitzer BL, Kamath MB, Jones D, Tagoh H, Bonifer C, Hildeman DA, and Huang KJ. Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells. J Biol Chem 282: 14194-14204, 2007. (Pubitemid 47100414)
9. Ertl RP, Chen J, Astle CM, Duffy TM, and Harrison DE. Effects of dietary restriction on hematopoietic stem-cell aging are genetically regulated. Blood 111: 1709-1716, 2008. (Pubitemid 351213463)
10. Fry TJ and Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174: 6571-6576, 2005. (Pubitemid 40705615)
11. Goldacre MJ, Wotton CJ, Seagroatt V, and Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 89: 1014-1017, 2004.
12. Harrison DE, Jordan CT, Zhong RK, and Astle CM. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol 21: 206-219, 1993. (Pubitemid 24216758)
13. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW, and Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431: 997-1002, 2004. (Pubitemid 39434422)
14. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, and Suda T. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. NatMed 12: 446-451, 2006.
15. Jovanovic SV, Clements D, and MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 25: 1044-1048, 1998. (Pubitemid 28558330)
16. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, and Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109-1121, 2005. (Pubitemid 40884400)
17. Kim HR, Hong MS, Dan JM, and Kang I. Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood 107: 2855-2862, 2006.
18. Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, and Crispino JD. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 111: 767-775, 2008.
19. Kondo M, Weissman IL, and Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672, 1997. (Pubitemid 27513657)
20. Kusters MA, Verstegen RH, Gemen EF, and de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 156: 189-193, 2009.
21. Lawson VJ, Weston K, and Maurice D. Egr2 regulates the survival of thymocytes during positive selection. Eur J Immunol 40: 232-241, 2010.
22. Lee HC, Shibata H, Ogawa S, Maki K, and Ikuta K. Transcriptional regulation of the mouse IL-7 receptor alpha promoter by glucocorticoid receptor. J Immunol 174: 7800-7806, 2005. (Pubitemid 40806288)
23. Malin S, McManus S, Cobaleda C, Novatchkova M, Delogu A, Bouillet P, Strasser A, and Busslinger M. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 11: 171-179, 2010.
24. Mazzucchelli R and Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 7: 144-154, 2007. (Pubitemid 46178275)
25. Miller JP and Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 171: 2326-2330, 2003. (Pubitemid 37025538)
26. Morrison SJ, Wandycz AM, Hemmati HD, Wright DE, and Weissman IL. Identification of a lineage of multipotent hematopoietic progenitors. Development 124: 1929-1939, 1997. (Pubitemid 27270262)
27. Muller-Sieburg CE, Cho RH, Karlsson L, Huang JF, and Sieburg HB. Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness. Blood 103: 4111-4118, 2004. (Pubitemid 38685351)
28. Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, and Crispino JD. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood 101: 4298-4300, 2003. (Pubitemid 36857792)
29. Parmar K, Mauch P, Vergilio JA, Sackstein R, and Down JD. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 104: 5431-5436, 2007. (Pubitemid 47175697)
30. Pujal JM and Gallardo D. PCR-based methodology for molecular microchimerism detection and quantification. Exp Biol Med (Maywood) 233: 1161-1170, 2008.
31. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, and Davisson MT. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11: 177-184, 1995.
32. Rice GC, Bump EA, Shrieve DC, Lee W, and Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res 46: 6105-6110, 1986. (Pubitemid 17221738)
33. Richtsmeier JT, Baxter LL, and Reeves RH. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dyn 217: 137-145, 2000. (Pubitemid 30080493)
34. Rossi DJ, Bryder D, and Weissman IL. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol 42: 385-390, 2007. (Pubitemid 46561181)
35. Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, Chandrasekaran T, Chapiro E, Gesk S, Griffiths M, Guttery DS, Haferlach C, Harder L, Heidenreich O, Irving J, Kearney L, Nguyen-Khac F, Machado L, Minto L, Majid A, Moorman AV, Morrison H, Rand V, Strefford JC, Schwab C, Tonnies H, Dyer MJ, Siebert R, and Harrison CJ. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 114: 2688-2698, 2009.
36. Schlenner SM, Madan V, Busch K, Tietz A, Laufle C, Costa C, Blum C, Fehling HJ, and Rodewald HR. Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity 32: 426-436, 2010.
37. Scholzen T and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322, 2000. (Pubitemid 30054364)
38. Sejas DP, Rani R, Qiu Y, Zhang X, Fagerlie SR, Nakano H, Williams DA, and Pang Q. Inflammatory reactive oxygen species-mediated hemopoietic suppression in Fanccdeficient mice. J Immunol 178: 5277-5287, 2007. (Pubitemid 46595313)
39. Serwold T, Ehrlich LI, and Weissman IL. Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis. Blood 113: 807-815, 2009.
40. Serwold T, Ehrlich LIR, and Weissman IL. Reductive isolation from bone marrow and blood implicates common lymphoid progenitors as the major source of thymopoiesis. Blood 113: 807-815, 2009.
41. Sitnicka E, Buza-Vidas N, Ahlenius H, Cilio CM, Gekas C, Nygren JM, Mansson R, Cheng M, Jensen CT, Svensson M, Leandersson K, Agace WW, Sigvardsson M, and Jacobsen SE. Critical role of FLT3 ligand in IL-7 receptor independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors. Blood 110: 2955-2964, 2007. (Pubitemid 350006949)
42. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, and Bianchi DW. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci USA 106: 9425-9429, 2009.
43. Spangrude GJ, Heimfeld S, and Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62, 1988.
44. Stephan RP, Lill-Elghanian DA, and Witte PL. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J Immunol 158: 1598-1609, 1997. (Pubitemid 127469513)
45. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, Armstrong SA, Passegue E, DePinho RA, and Gilliland DG. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325-339, 2007. (Pubitemid 46137992)
46. Yilmaz OH, Kiel MJ, and Morrison SJ. SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity. Blood 107: 924-930, 2006. (Pubitemid 43156288)